• Tue, August 3, 2021

Brian Cheng Initiated (BCRX) at Buy and Held Target at $21 on, Aug 3rd, 2021

Brian Cheng of Cantor Fitzgerald, Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Buy and Held Target at $21 on, Aug 3rd, 2021.

Brian, nor any peers, have made any analyst calls on BCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30